| Name | Title | Contact Details |
|---|
DAST Consulting Services is a rapidly growing company that is part of a consortium of organizations with a vision to unlock financial resources so that every kid in America has access to a Christ-centered education. We collaborate with accredited non-public schools to help them leverage various revenue streams, including federal and state grant funding programs as well as innovative work-based learning initiatives. DAST also has an active venture studio (DAST Investments) with multiple portfolio companies, and a nonprofit (DAST Foundation) that recently launched a Classical Christian Microschool network.
Stellar is a manufacturer and distributor of domestic hydraulic hook-lift hoist and accessories.
Carrington Fox is a boutique executive search firm founded in 2001, based in New York City. The company specializes in human capital solutions for global financial markets, focusing on executive and contingent search mandates. With a team of approximately 25 to 50 employees, Carrington Fox generates an estimated annual revenue between $5 million and $25 million. The firm serves clients in investment banking, private equity, hedge funds, tax, accounting, and quantitative analytics. They emphasize long-term partnerships, aiming to understand client needs and candidate aspirations deeply. Carrington Fox is known for its niche expertise in front-office financial roles and quantitative disciplines, providing tailored recruitment processes with a commitment to confidentiality and efficiency.
Continental Generals mission is to assist our customers with managing the financial risks and challenges that come as they age. Our skills, resources, and infrastructure allow us to help them with insulating and enhancing retirement income and maneuvering caregiving options. Thus allowing us to responsibly be a part of the solution rather than the problem. Our team of long-term care industry experts, with headquarters in Austin, Texas, strives to build value through superior operating results. As we manage our current portfolio of business, we continue to pursue growth opportunities for expansion and economies of scale through strategic acquisitions, mergers, and reinsurance opportunities. Our family of insurance companies and strategic partners provide administrative services to approximately 125,000 Long-Term Care, Life, Annuity and Supplemental Health customers. We are dedicated to upholding the commitments we have made to provide excellent service to all our customers and serve the needs of our claimants and their families during difficult times.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.